Provides improved cancer prognosis over the original score, based on serum biomarkers.
The Modified Glasgow Prognosis Score helps stratify prognosis groups and may be a worthy addition to multifactorial evaluations. As a stand-alone in individual cases it is unclear at this point how accurate it is likely to be.
We are unaware of validated management algorithms using the mGPS.
The modified GPS does not assign a point for low albumin as a singular finding, which is different from the original GPS. The c-reactive protein value must be elevated for points to be assigned.